Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Abpro, Adagene, Antengene, Astrazeneca, Celltrion.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Ascletis, Astellas, Innocare, Innovent, Neuexcell, Radiopharm, Sol-Gel, Takeda, .
